Simon Aoyama
About Simon Aoyama
Simon Aoyama is an Associate Scientist currently working at Mythic Therapeutics in Waltham, Massachusetts. He has extensive experience in the field of research, having held positions at various institutions including Axcella and Pronutria, and has contributed to significant publications and conferences.
Work at Mythic Therapeutics
Simon Aoyama has been serving as an Associate Scientist at Mythic Therapeutics since 2018. His role involves contributing to the development of innovative therapeutic solutions. Located in Waltham, Massachusetts, Mythic Therapeutics focuses on advancing treatments for various diseases through cutting-edge research and development.
Previous Experience in Biotechnology
Prior to his current position, Simon Aoyama worked at Axcella as an Associate Scientist in Discovery from 2017 to 2018. He also held the role of Senior Research Associate at Axcella from 2016 to 2017. His experience includes working at Pronutria as a Research Associate in Discovery from 2015 to 2016, and at the Broad Institute as a Research Associate in the Genomic Perturbation Platform from 2012 to 2013. Additionally, he worked at Hepregen Corporation as a Research Associate in Research and Development from 2010 to 2012.
Education and Expertise
Simon Aoyama earned a Bachelor of Science degree in Neuroscience from Brandeis University, where he studied from 2007 to 2010. His academic background provides a strong foundation for his research work in the biotechnology field. He has developed expertise in various aspects of scientific research, particularly in drug discovery and development.
Research Contributions and Publications
Simon Aoyama contributed to a journal article on MYTX-011, a pH-dependent anti-cMET antibody-drug conjugate, which was published in April 2024. His research efforts have been recognized at major conferences, including presentations related to MYTX-011 at the American Association of Cancer Research (AACR) Annual Meeting in April 2023 and the American Society of Clinical Oncology (ASCO).
Professional Development and Networking
Simon Aoyama actively participates in professional events to enhance his knowledge and network within the scientific community. His involvement in the AACR Annual Meeting in April 2023 highlights his commitment to staying updated on the latest advancements in cancer research and biotechnology.